Soluble trail has better efficacy than full-length membrane-bound trail, and in combination with akti blocks pro-metastatic cytokine production in prostate cancer cells
Year: 2021
Type: article
Source: Cytotherapy
Authors: A. Mohr, C. Tianyuan, G. Brooke, R.M. Zwacka
Institution: University of Essex
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3163072001
